Terumo Makes Big Bet On Aneurysm Embolization With Sequent Acquisition
This article was originally published in Clinica
Executive Summary
Terumo will pay up to $380m for privately-held Sequent Medical to and improve its presence in the US neurovascular device market with Sequent’s WEB embolization system for treatment of wide-neck bifurcation intracranial aneurysms, the Japanese medtech giant announced on June 16.